Literature DB >> 23962054

(-)-Arctigenin as a lead compound for anticancer agent.

Gui-Rong Chen1, Hong-Fu Li, De-Qiang Dou, Yu-Bin Xu, Hong-Shuai Jiang, Fu-Rui Li, Ting-Guo Kang.   

Abstract

(-)-Arctigenin, an important active constituent of the traditional Chinese herb Fructus Arctii, was found to exhibit various bioactivities, so it can be used as a good lead compound for further structure modification in order to find a safer and more potent medicine. (-)-Arctigenin derivatives 1-5 of (-)-arctingen were obtained by modifying with ammonolysis at the lactone ring and sulphonylation at C (6') and C (6″) and O-demethylation at CH3O-C (3'), CH3O-C (3″) and CH3O-C (4″), and their anticancer bioactivities were examined.

Mesh:

Substances:

Year:  2013        PMID: 23962054     DOI: 10.1080/14786419.2013.821120

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

1.  Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes.

Authors:  Yifei Zhong; Kyung Lee; Yueyi Deng; Yueming Ma; Yiping Chen; Xueling Li; Chengguo Wei; Shumin Yang; Tianming Wang; Nicholas J Wong; Alecia N Muwonge; Evren U Azeloglu; Weijia Zhang; Bhaskar Das; John Cijiang He; Ruijie Liu
Journal:  Nat Commun       Date:  2019-10-04       Impact factor: 14.919

2.  The Ameliorative Effects of Arctiin and Arctigenin on the Oxidative Injury of Lung Induced by Silica via TLR-4/NLRP3/TGF-β Signaling Pathway.

Authors:  Xueying Liu; Jian Wang; Peiyuan Dou; Xu Zhang; Xiaoku Ran; Linlin Liu; Deqiang Dou
Journal:  Oxid Med Cell Longev       Date:  2021-07-17       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.